Los Angeles, CA March 22, 2018 -- California Cryobank (CCB), the worldwide leader in frozen donor sperm and donor egg banking, announced today Geoffrey Crouse is joining the company's Board of Directors. Crouse adds a wealth of experience and expertise to CCB’s rapidly growing Stem Cell Division, which features FamilyCord, one of the country's leading private cord blood and cord tissue banks.
"We are pleased to have Geoff join the CCB Board," said CEO, Richard Jennings. "His deep professional background and his commitment to life sciences will bring insightful perspectives to our Board."
"I am delighted to join the board and look forward to working with the talented management team as California Cryobank continues to build their newborn stem cell banking platform." Crouse said.
"Geoff is an extremely well-respected leader in the stem cell industry who will add a valuable dimension to our Board and to our rapidly growing FamilyCord business," added Chief Operating Officer, Pamela Richardson.
Crouse is the CEO of Syneron Candela, and previously served as CEO of CBR (Cord Blood Registry) from 2012-2015. Prior to CBR, he served as Chief Operating Officer at Immucor, a publicly traded global in vitro diagnostics company. Prior to Immucor, he served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry.
About California Cryobank
For over 40 years, California Cryobank has helped to create and protect families around the world through frozen donor sperm and frozen donor egg services, reproductive tissue storage, and cord blood banking through FamilyCord. Operating throughout the United States, Europe, Latin America, Australia, and Asia, CCB is registered with the FDA, accredited by the AATB and AABB, and licensed by the states of California and New York. Cryobank is a portfolio company of two healthcare-focused private investment firms, Longitude Capital and NovaQuest Capital Management.